JW Pharmaceutical Corporation (KRX:001065)

South Korea · Delayed Price · Currency is KRW · Preferred Stock

26,400

+50 (0.19%)

Apr 16, 2026, 11:30 AM KST

-3.47% (1Y)

Market Cap	729.69B +34.6%
Revenue (ttm)	775.30B +7.8%
Net Income	61.51B -5.4%
EPS	2,534.00 -4.2%
Shares Out	n/a
PE Ratio	11.86
Forward PE	n/a
Dividend	675.00 (2.53%)
Ex-Dividend Date	Mar 31, 2026

Volume	412
Average Volume	282
Open	26,350
Previous Close	26,350
Day's Range	26,350 - 26,400
52-Week Range	26,000 - 30,300
Beta	n/a
RSI	42.19
Earnings Date	Mar 20, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base... [Read more]

Industry Pharmaceutical Preparations

Sector Healthcare

Founded 1945

Employees 1,068

Stock Exchange Korea Stock Exchange

Ticker Symbol 001065